Gene expression profiling as a helpful tool to identify the predictive potential of ex-vivo head and neck cancer models

Introduction The development of patient-specific preclinical models to assess therapy response in HNSCC is an ambitious goal ("personalised medicine"). However isolated cells from patient material are affected by isolation/expansion methods and change their properties. This study aims to show whether gene expression profiling can be used to analyse the reliability of the chosen model.